Antigen-specific challenge of equine leukocytes induced the non-lytic release of a platelet-activating factor in vitro. The equine platelet-activating factor stimulated the release of serotonin from equine platelets in a dose-responsive manner, independent of the presence of cyclo-oxygenase pathway inhibitors such as indomethacin. Rabbit platelets were also responsive to equine platelet-activating factor. The release of equine platelet-activating factor was a rapid reaction with near maximal secretion taking place in 30 seconds. Addition of equine platelet-activating factor to washed equine platelets stimulated platelet aggregation which could not be inhibited by the presence of aspirin or indomethacin. Platelets preincubated with equine platelet-activating factor became specifically desensitized to equine platelet-activating factor while remaining responsive to other platelet stimuli such as collagen and epinephrine.
The following biochemical properties of equine platelet-activating factor are identical to those properties of 1-0-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine (AGEPC): stability upon exposure to air and acid; loss of functional activity after basecatalyzed methanolysis with subsequent acylation that returned all functional activity; and identical relative mobilities on silica gel G plates developed with chloroform:methanol:water (65:35:6, volume/volume). The combined functional and biochemical characteristics of equine platelet-activating factor strongly suggest identity between this naturally occurring, immunologically derived equine factor and AGEPC.
BenvenisteJ.HensonP.M.CochraneC.G.:
Leukocyte-dependent histamine release from rabbit platelets. The role of IgE, basophils, and a platelet-activating factor.J Exp Med136:
1356–1377,
1972
3.
BenvenisteJ.JouvinE.PirotzkyE.ArnouxB.Mencia-HuertaJ.M.RoubinR.VargaftigB.B.:
Platelet-activating factor (PAF-acether): Molecular aspects of its release and pharmacological activity.Int Arch Allergy Appl Immunol
(Suppl 1)
66:
121–126,
1981
4.
BoothB.H.PattersonR.TalbotC.H.:
Immediatetype hypersensitivity in dogs: Cutaneous, anaphylactic and respiratory responses to ascaris.J Lab Clin Med,76:
181–189,
1970
5.
CammussiG.TettaC.CodaR.BenvenisteJ.:
Release of platelet-activating factor in human pathology. I. Evidence for the occurrence of basophil degranulation and release of platelet-activating factor in systemic lupus erythematosus.Lab Invest44:
241–251,
1981
6.
ChignardM.VargaftigB.B.BenvenisteJ.Le CouedicJ.-P.:
L'agregation plaquettaire et le plateletactivating factor.J Pharmacol11:
371–377,
1980
7.
DemopoulosC.A.PinckardR.N.HanahanD.J.:
Platelet-activating factor: Evidence for 1-0-alkyl-2-acetyl-sn-glyceryl-3-phosphoryl-choline as the active component (A new class of lipid chemical mediators).J Biol Chem254:
9355–9358,
1979
8.
DobsonC.MorsethD.J.SoulsbyE.J.L.:
Immunoglobulin E type antibodies induced by Ascaris suum infections in guinea pigs.J Immunol106:
128–133,
1971
9.
FantoneJ.C.WardP.A.:
Role of oxygen-derived free radicals and metabolites in leukocyte-dependent inflammatory reactions.Am J Pathol107:
397,
1982
10.
GoetzlE.J.DerianC.K.TauberA.I.ValoneF.H.:
Novel effects of 1-0-hexadecyl-2-acyl-sn-glycero-3-phosphorycholine mediators on human leukocyte function: Delineation of the specific roles of the acyl substituents.Biochem Biophys Res Commun94:
881,
1980
11.
HalonenM.PalmerJ.D.LohmanI.C.McManusL.M.PinckardR.N.:
Respiratory and circulatory alterations induced by acetyl glyceryl ether phosphorylcholine (AGEPC), a mediator of IgE anaphylaxis in the rabbit.Am Rev Respir Dis122:
915–924,
1980
12.
HanahanD.J.DemopoulosC.A.LiehrJ.PinckardR.N.:
Identification of platelet-activating factor isolated from rabbit basophils as acetyl glyceryl ether phosphorylcholine.J Biol Chem225:
5514–5516,
1980
13.
HensonP.M.:
Activation and desensitization of platelets by platelet-activating factor (PAF) derived from IgE-sensitized basophils I. Characteristics of the secretory response.J Exp Med143:
937–952,
1976
14.
HensonP.M.:
Activation of rabbit platelets by plateletactivating factor derived from IgE-sensitized basophils. Characteristics of the aggregation and its dissociation from secretion.J Clin Invest60:
481–490,
1977
15.
HensonP.M.CochraneC.G.:
Acute immune complex disease in rabbits: The role of complement and of a leukocyte-dependent release of vasoactive amines from platelets.J Exp Med133:
554,
1971
16.
HensonP.M.OadesZ.G.:
Activation of platelets by platelet-activating factor (PAF) derived from IgE-sensitized basophils II. The role of serine proesterases, cyclic nucleotides, and contractile elements in PAF-induced secretion.J Exp Med143:
953–968,
1976
17.
HolmsenH.OstvoldA.DagJ.H.:
Behavior of endogenous and newly absorbed serotonin in the platelet release reaction.Biochem Pharmacol22:
2599–2609,
1973
18.
McManusL.M.HanahanD.J.DemopoulosC.A.PinckardR.N.:
Pathobiology of the intravenous infusion of acetyl glyceryl ether phosphorylcholine (AGEPC), a synthetic platelet-activating factor (PAF), in the rabbit.J Immunol124:
2919–2924,
1980
19.
McManusL.M.HanahanD.J.PinckardR.N.:
Human platelet stimulation by acetyl glyceryl ether phosphorycholine (AGEPC).J Clin Invest67:
903–906,
1981
20.
McManusL.M.PinckardR.N.FitzpatrickF.F.O'RourkeR.A.CrawfordM.H.HanahanD.J.:
Acetyl glyceryl phosphorylcholine (AGEPC): Intravascular alterations following intravenous infusion in the baboon.Lab Invest45:
303–307,
1981
21.
MalleyA.AmkrautA.A.StrejanG.CampbellD.H.:
Hypersensitivity induced in Rhesus monkeys.J Immunol101:
292–300,
1968
22.
MeyersM.M.LindnerC.L.GrantB.:
Characteristics of the equine platelet aggregation response.Am J Vet Res40:
260–264,
1979
23.
O'DonnellM.C.HensonP.M.FiedelB.A.:
Activation of human platelets by platelet-activating factor (PAF) derived from sensitized rabbit basophils.Immunology35:
953–958,
1979
24.
O'FlahertyJ.T.:
Lipid mediators of inflammation and allergy.Lab Invest47:
314–329,
1982
25.
O'FlahertyJ.T.LeesC.J.MillerC.H.McCallC.E.LewisJ.C.LoveS.H.WykleR.:
Selective desensitization of neutrophils: Further studies with 1-0-aldyl-sn-glycero-3-phosphocholine analogues.J Immunol127:
731,
1981
26.
O'FlahertyJ.T.MillerC.H.LewisJ.C.WykleR.L.BassD.A.McCallC.E.WaiteM.De-ChateletL.R.:
Neutrophil responses to platelet-activating factor.Inflammation5:
193,
1981
27.
O'FlahertyJ.T.WykleR.L.MillerC.H.LewisJ.C.WaiteM.BassD.A.McCallC.E.De-ChateletL.R.:
1-0-alkyl-sn-glyceryl-3-phosphorylcholines: A novel class of neutrophil stimulants.Am J Pathol103:
70,
1981
28.
PinckardR.N.:
The new chemical mediators of inflammation.In:
Current Topics in Inflammation and Infection,
eds. MajnoG.CotranR. S.KaufmanN.,
pp. 38–53.
Williams & Wilkins,
Baltimore, MD,
1982
29.
PinckardR.N.FarrR.S.HanahanD.J.:
Physiochemical and functional identity of rabbit platelet-activating factor (PAF) released in vivo during IgE anaphylaxis with PAF released in vitro from IgE sensitized basophils.J Immunol123:
1847–1857,
1979
30.
PinckardR.N.HalonenM.PalmerJ.D.ButlerC.ShawJ.O.HensonP.M.:
Intravascular aggregation and pulmonary sequestration of platelets during IgE-induced systemic anaphylaxis in the rabbit: Abrogation of lethal anaphylactic shock by platelet depletion.J Immunol119:
2179–2192,
1977
31.
PinckardR.N.McManusL.M.DemopoulosC.A.HalonenM.ClarkP.O.ShawJ.O.KnikerW.T.HanahanD.J.:
Molecular pathobiology of acetyl glyceryl ether phosphorylcholine (AGEPC): Evidence for the structural identity with platelet-activating factor.J Reticuloendothel Soc28:
95–103,
1980
PinckardR.N.McManusL.M.HanahanD.J.:
Chemistry and biology of acetyl glyceryl ether phosphorylcholine (platelet-activating factor).Adv Inflamm Res4:
147–180,
1982
34.
SchacterleG.R.PollackR.L.:
A simplified method for the quantitative assay of small amounts of protein in biologic material.Anal Biochem51:
654–655,
1969
35.
ShawJ.O.PinckardR.N.FerrigniK.S.McManusL.M.HanahanD.J.:
Activation of human neutrophils with 1-0-hexadecyl/octadecyl-2-acetyl-sn-glyceryl-3-phosphorylcholine (platelet activating factor).J Immunol127:
1250,
1981
36.
SlausonD.O.Sanchez-VizcainoJ.M.:
Leukocyte-dependent platelet vasoactive amine release and immune complex deposition in African swine fever.Vet Pathol18:
813–826,
1981
37.
StimlerN.P.BloorC.M.HugliT.E.WykleR.L.McCallC.E.O'FlahertyJ.T.:
Anaphylactic actions of platelet-activating factor.Am J Pathol105:
64,
1981
38.
StrejanG.H.:
Allergens of ascaris and other nematodes.In:
Immediate Hypersensitivity: Modern Concepts and Developments,
ed. Bach
pp. 694–736.
Marcel Dekker,
New York,
1978
39.
SuquetC.M.LeidR.W.:
Aggregation of equine platelets by PAF (platelet-activating factor).Inflammation7:
197–203,
1983
40.
SuterM.FeyH.:
Isolation and characterization of equine IgE.Zentralbl Veterinaermed [B]28:
414–420,
1981
41.
SuterM.FeyH.:
Further purification and characterization of horse IgE.Vet Immunol Immunopathol4:
545–554,
1983
42.
TomissawaS.:
A new method for rapid separation of platelets from plasma by discontinuous ficoll density gradient.Jpn J Exp Med45:
529–531,
1975
43.
VargaftigB.B.ChignardM.BenvenisteJ.LefortJ.WalF.:
Background and present status of research on platelet-activating factor (PAF-acether).Ann NY Acad Sci118:
119–137,
1981
44.
VargaftigB.B.ChignardM.Le CouedicM.-P.BenvenisteJ.:
One, two, three or more pathways for platelet aggregation.Acta Med Scand [Suppl]642:
23–29,
1980
45.
WroblewskiF.LaDueJ.S.:
Lactic dehydrogenase activity in the blood.Proc Soc Exp Biol Med90:
210–213,
1955
